Abdolreza Esmaeilzadeh (A Esmaeilzadeh)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Nanomedicine (London, England)

Stem cell reviews and reports

Cancer cell international

Journal of cellular physiology

Zanjan University of Medical Sciences

Tarbiat Modares University Faculty of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zanjan University of Medical Sciences

Iran

Faculty :: Immunology

Education History

Tarbiat Modares University Faculty of Medical Sciences

Iran

PHD :: Immunology

Tehran University of Medical Sciences

Iran

BSC :: Paramedical Science

Shahid Beheshti University of Medical Sciences

Iran

MSC :: Immunology

Publications

Abdolreza Esmaeilzadeh, Pegah Moharrami Yeganeh, Mahdis Nazari, Kimia Esmaeilzadeh
Platelet-derived extracellular vesicles: a new-generation nanostructured tool for chronic wound healing. Nanomedicine (London, England) 19 (10) (2024)
Abdolreza Esmaeilzadeh, Pegah Moharrami Yeganeh, Mahdis Nazari, Kimia Esmaeilzadeh
Platelet-derived extracellular vesicles: a new-generation nanostructured tool for chronic wound healing. Nanomedicine (London, England) 19 (10) (2024)
Abdolreza Esmaeilzadeh, Pegah Moharrami Yeganeh, Mahdis Nazari, Kimia Esmaeilzadeh
Platelet-derived extracellular vesicles: a new-generation nanostructured tool for chronic wound healing. Nanomedicine (London, England) 19 (10) (2024)
Vahid Mohammadi, Kimia Esmaeilzadeh, Abdolreza Esmaeilzadeh
Application of magnetic nanoparticles in adoptive cell therapy of cancer; training, guiding and imaging cells. Nanomedicine (London, England) (2024)
Abdolreza Esmaeilzadeh, Pegah Moharrami Yeganeh, Mahdis Nazari, Kimia Esmaeilzadeh
Platelet-derived extracellular vesicles: a new-generation nanostructured tool for chronic wound healing. Nanomedicine (London, England) (2024)
Vahid Mohammadi, Armin Jahani Maleki, Mahdis Nazari, Amir Siahmansouri, Amirhosein Moradi, Reza Elahi, Abdolreza Esmaeilzadeh
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches. Stem cell reviews and reports (2023)
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy. Cancer cell international 23 (1) (2023)
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy. Cancer cell international 23 (1) (2023)
Vahid Mohammadi, Armin Jahani Maleki, Mahdis Nazari, Amir Siahmansouri, Amirhosein Moradi, Reza Elahi, Abdolreza Esmaeilzadeh
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches. Stem cell reviews and reports 20 (3) (2023)
Vahid Mohammadi, Armin Jahani Maleki, Mahdis Nazari, Amir Siahmansouri, Amirhosein Moradi, Reza Elahi, Abdolreza Esmaeilzadeh
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches. Stem cell reviews and reports 20 (3) (2023)
Pegah Moharrami Yeganeh, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Cellular and biological factors involved in healing wounds and burns and treatment options in tissue engineering. Regenerative medicine 17 (6) (2022)
Reza Elahi, Amir Hossein Heidary, Kaveh Hadiloo, Abdolreza Esmaeilzadeh
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects. Stem cell reviews and reports 17 (6) (2021)
Davood Jafari, Mohammad Javad Mousavi, Sanaz Keshavarz Shahbaz, L Jafarzadeh, Safa Tahmasebi, J Spoor, Abdolreza Esmaeilzadeh
E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy. Clinical and experimental immunology 204 (1) (2021)
Abdolreza Esmaeilzadeh, Reza Elahi
Immunobiology and immunotherapy of COVID-19: A clinically updated overview. Journal of cellular physiology 236 (4) (2020)
S Tahmasebi, R Elahi, E Khosh, Abdolreza Esmaeilzadeh
Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (6) (2020)
Safa Tahmasebi, Elnaz Khosh, Abdolreza Esmaeilzadeh
The outlook for diagnostic purposes of the 2019-novel coronavirus disease. Journal of cellular physiology 235 (12) (2020)

Abdolreza Esmaeilzadeh.css-eqlu8i{font-size:small;padding-left:4px;} (A Esmaeilzadeh)

Publication Activity (10 Years)

Top Topics

Top Venues

Abdolreza Esmaeilzadeh (A Esmaeilzadeh)